My understanding is that the Government of Canada has spoken with all the companies to see who might be interested in manufacturing in Canada. It would seem to be that Novavax was a company that wanted to do that.
Again, it's unprecedented to make billions of doses of vaccines in a very short period of time. If you look at worldwide supply and capacity for these vaccines, typically the constraint is the drug substance, the bulk manufacturing, fill and finish or formulating it and converting it into drug product. That is the bottleneck, so to start with looking at how you can have fill and finish capabilities and then transfer bulk manufacturing into Canada certainly is a way to go to fortify us for the intermediate and the longer term.